Maravai Lifesciences Holdings Inc (MRVI)
Maravai Lifesciences stock today
Maravai Lifesciences closed at $7.81 on October 30, 2026, down 7.68% on the day. Over the past year it returned +148.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.02 billion.
| Period | MRVI | S&P 500 (SPY) |
|---|---|---|
| 1 month | +2.0% | -0.9% |
| 3 months | +15.7% | +2.1% |
| Year to date | +140.3% | +11.7% |
| 1 year | +148.7% | +12.4% |
| 3 years | +11.6% | +88.5% |
| 5 years | -81.5% | +76.0% |
Key statistics
- Market value
- $2.02B
- Price / sales
- 9.7
- 52-week range
- $2.83 to $9.00
- Next report
- Nov 4, 2026
About Maravai Lifesciences
Manufactures reagents and enzymes for life sciences research and diagnostics.
Sector: Health Care
More on Maravai Lifesciences
- Financials: revenue, earnings and segmentsRevenue -28% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $184.68 today
No forecast, no recommendation. This page describes Maravai Lifesciences Holdings Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.